Stocks and Investing Stocks and Investing
Thu, October 6, 2016

Paul Matteis Downgraded (ALNY) to Hold and Decreased Target to $40 on, Oct 6th, 2016


Published on 2024-10-25 18:49:22 - WOPRAI, Paul Matteis
  Print publication without navigation


Paul Matteis of Leerink Swann, Downgraded "Alnylam Pharmaceuticals, Inc." (ALNY) to Hold and Decreased Target from $107 to $40 on, Oct 6th, 2016.

Paul has made no other calls on ALNY in the last 4 months.



There is 1 other peer that has a rating on ALNY. Out of the 1 peers that are also analyzing ALNY, 0 agree with Paul's Rating of Hold.



This is the rating of the analyst that currently disagrees with Paul


  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $83 on, Friday, August 5th, 2016

Contributing Sources